Clinical Research Directory
Browse clinical research sites, groups, and studies.
PET Detection of CCR2 in Human Atherosclerosis
Sponsor: Washington University School of Medicine
Summary
: Use of novel radio-pharmaceutical 64CUDOTA-ECL1i to evaluate arterial atherosclrosis
Key Details
Gender
All
Age Range
18 Years - 89 Years
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2020-10-01
Completion Date
2025-09-01
Last Updated
2025-08-01
Healthy Volunteers
Yes
Conditions
Interventions
Group 1-64CU-DOTA-ECL1i (radioactive imaging medicine)
Patients in Group 1, normal volunteers and patients with carotid and femoral artery disease who will be having surgery, will have a 1 day imaging session lasting approximately 60 minutes with an injection of 64CU-DOTA-ECL1i to visualize the carotid and femoral arteries. Patients with carotid and femoral artery disease will have their plaque specimens collected for further sutdy
Group 2 64CU-DOTA-ECL1i (radioactive imaging medicine)
Patients in Group 2, who are patients with carotid and femoral artery disease who will not be having surgery will have two imaging sessions 7-14 days apart
Locations (1)
Washington University CCIR
St Louis, Missouri, United States